Slingshot Insights | Nlnk Overview

NLNK Overview

Upcoming Projects (NLNK)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (NLNK)

Discussion of IDO inhibitors from a basic science and research perspective. Specifically discussing potential bioavailability and solubility issues.
Tickers: NLNK, BMY, RHHBY
Execute By: Apr 21, 2017

Upcoming & Overdue Catalysts (NLNK)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (NLNK)

NewLink Genetics (NLNK) Announces Two Abstracts Evaluating Indoximod Will Be Presented at the American Association for Cancer Research (AACR) 2017 Annual Meeting
Ticker: NLNK
Occurred on: Apr 04, 2017
Phase 3 data of HyperAcute Pancreas - IMPRESS trial for Surgically resected pancreatic cancer due 2016
Ticker: NLNK
Occurred on: May 09, 2016
NewLink Genetics Presents Phase 1b Data of Indoximod in Combination With Gemcitabine/Nab-Paclitaxel for Patients With Metastatic Pancreatic Cancer That Show Encouraging Durable Responses With Delayed Pattern
Ticker: NLNK
Occurred on: Jan 22, 2016

Strategic Initiatives (NLNK)

Don’t see a strategic initiative related to the company you care about? Create your own!